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Abstract
Rickettsioses are recognized as important emerging vector-borne infections of humans worldwide. Previous reports documented the
presence of two spotted fever group rickettsiae in Israel, Rickettsia conorii israelensis and Rickettsia felis. The aim of this study was to
characterize the diversity of rickettsiae in ticks collected from vegetation and the ground, from different parts of Israel. Non-engorged
questing adult ticks were collected from 13 localities. A total of 131 tick pools, 83 of Rhipicephalus turanicus and 48 of Rhipicephalus
sanguineus (each with 2–10 ticks per pool), were included in this study. In addition, 13 Hyalomma sp. ticks were collected. The ticks
were molecularly screened for rickettsiae, targeting the citrate synthase (gltA) and the outer membrane protein A (ompA) gene loci.
Rickettsia massiliae ompA DNA (100% sequence identity; 180 bp) was detected in 32 Rh. turanicus and 12 Rh. sanguineus tick pools. R. co-
norii israelensis was detected in three Rh. sanguineus pools. Rickettsia sibirica mongolitimonae ompA DNA (100% sequence identity; 182 bp)
was found in one Hyalomma tick. This study reports the ﬁrst detection of R. massiliae and R. sibirica mongolitimonae in ticks from Israel.
This is the ﬁrst report describing the presence of these human pathogens in the Middle East.
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Introduction
Rickettsioses are recognized as important emerging vector-
borne infections of humans worldwide. They are caused by
obligate intracellular Gram-negative bacteria of the genus Rick-
ettsia (family Rickettsiacea). Spotted fever group rickettsioses
are characterized by fever, headache, rash and potential eschar
formation at the bite site [1,2]. Two spotted fever group rick-
ettsiae have been detected and characterized in Israel to date,
Rickettsia conorii israelensis, the aetiological agent of Israeli spot-
ted fever (ISF), and Rickettsia felis, the aetiological agent of ﬂea-
borne spotted fever. Israel is considered to be an endemic
region for ISF, and clinical cases are commonly presented. In
contrast, clinical cases attributed to R. felis in Israeli patients
have not been reported to date [3–5].
Arthropod vectors have been screened extensively for the
diversity of the pathogens that they carry. The introduction
of molecular techniques in the last two decades has resulted
in increased detection of emerging and re-emerging vector-
borne pathogens in different parts of the world [6]. The aim
of this study was to characterize the diversity of rickettsiae
in ticks collected from vegetation and the ground in different
parts of Israel.
Materials and Methods
Tick collection
Non-engorged questing adult ticks were collected from 13
localities in the vicinity of human habitations in three differ-
ent geographical regions in Israel (Caesarea, Pardes Hana,
Michmoret and Alexander valley in the north; Tel Aviv, Bet
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Arif, Mazkeret Batia, Kibbutz Hulda and Kibbutz Harel in the
centre; and Or Haner, Bror Hail, Reim and Tzeelim in the
south). Ticks were collected from vegetation of up to 30 cm
in height with the ﬂagging technique. In addition, some ticks
were collected directly from the vegetation or while moving
on the ground. The ticks were identiﬁed morphologically by
an experienced entomologist. A total of 1196 non-engorged
adult ticks identiﬁed as Rhipicephalus sanguineus (Latreille,
1806), Rhipicephalus turanicus (Pomerantsev, 1936) and Hya-
lomma sp. were collected during 2002–2003 and 2007–2008.
Ticks of the same species collected on the same date and from
the same location were pooled together in one vial. Ticks
collected during the years 2002–2003 were kept in a medium
containing 10% fetal bovine serum and 10% antibiotics/
antimycotics (10 mg/mL streptomycin sulphate, 10 000 U/mL,
penicillin G sodium, and 25 mg/L amphotericin B), and
ticks collected during the years 2007–2008 were kept in
70% ethanol. All ticks were frozen at )70C until DNA
extraction.
DNA extraction, real-time PCR ampliﬁcation and sequencing
After elimination of the ethanol and medium remains from
each vial containing ticks, 50 mL of phosphate-buffered saline
was added. Each sample was manually homogenized with
plastic microtube pestles for 1 min, and then centrifuged for
10 s at 2000 g. The upper fraction was collected from each
vial, and DNA was extracted with a DNA extraction kit
(Illustra Tissue Mini Spin kit; GE Healthcare, Little Chalfont,
UK), according to the manufacturer’s instructions. Initial
detection of Rickettsia species was performed by screening all
DNA samples by a real-time PCR assay targeting a 133-bp
fragment of the citrate synthase gene (gltA), using primers
rico173F (CGACCCGGGTTTTATGTCTA) and rico173R
(ACTGCTCGCCACTTGGTAGT), designed for this study.
Real-time PCR was carried out with an initial hold for
15 min at 95C, followed by 50 cycles of 5 s at 95C, 30 s
at 57C (ﬂuorescence acquisition on the HRM channel) and
1 s at 72C. The melting phase started at 60C, each step
rising by 1C (ﬂuorescence acquisition on the HRM channel),
and ﬁnished at 90C with a hold for 90 s at the ﬁrst step
and 5 s at the subsequent steps. Hybridization started at
90C and fell to 50C, by 1C at each step. The positive
samples were further analysed by targeting a 178–189-bp
fragment of the outer membrane protein A gene (ompA),
using primers 107F (GCTTTATTCACCACCTCAAC) and
299R (TRATCACCACCGTAAGTAAAT) [7], with an initial
hold for 15 min at 95C, followed by 50 cycles of 10 s at
95C, 30 s at 56C (ﬂuorescence acquisition on the HRM
channel) and 6 s at 72C. The melting phase started at 60C,
each step rising by 1C (ﬂuorescence acquisition on the
HRM channel), and ﬁnished at 95C with a hold for 90 s at
the ﬁrst step and 1 s at the subsequent steps. Hybridization
started at 90C and fell to 50C, by 1C at each step. Both
real-time PCR reactions were carried out using the Rotor
Gene 6000 cycler (Corbett Research, Sydney, Australia).
PCR was performed in 20-lL reaction volumes containing
4 lL of DNA, 1.5 lL of each primer, 0.6 lL of cyto9, 2.4 lL
of double-distilled water, and 10 lL of Thermo-Start PCR
Master Mix (Thermo Scientiﬁc, Loughborough, UK). DNA
extracted from cultured R. conorii israelensis was used as a
positive control, and two negative control samples containing
all the ingredients of the reaction except DNA were used
for all trials.
PCR products were puriﬁed using a PCR puriﬁcation kit
(ExoSAP-IT; USB, Cleveland, OH, USA) and sequenced. DNA
sequencing was carried out by utilizing the BigDye terminator
cycle sequencing chemistry from an Applied Biosystems ABI
3700 DNA Analyzer (Foster City, CA, USA), and the ABIs
data collection and sequence analysis software. Further analy-
sis was performed with Sequencher software, version 4.8
(Gene Codes Corporation, Ann Arbor, MI, USA).
Results
Ticks
A total of 131 pools, 83 of Rh. turanicus and 48 of Rh. san-
guineus, each with 2–10 adult ticks per pool, were included
in this study. In addition, 13 adult ticks of Hyalomma spp.
were placed in single tubes and analysed separately.
Rickettsiae
The rickettsial gltA gene fragment was detected and
sequenced in 23 of the 48 (48%) Rh. sanguineus tick pools, in
51 of the 83 (61%) Rh. turanicus tick pools, and in ﬁve of the
13 (38%) Hyalomma sp. ticks. Sequences of the gltA fragment
were identical in most of the tested samples (99–100%
sequence identity to a large number of rickettsial species and
strains), and could not assist in species identiﬁcation. There-
fore, the ompA gene was further targeted. Table 1 shows the
ompA gene sequence similarities observed with respect to
those deposited in GenBank.
Rickettsial ompA DNA was found in 16 of the 23 gltA-posi-
tive Rh. sanguineus pools (Table 1), 12 of which were positive
for Rickettsia massiliae. All of these sequences were identical
and were deposited in GenBank (new accession number
GU212859); ompA DNA from three Rh. sanguineus pools was
identical to that from R. conorii israelensis. The three
sequences were also identical to each other and were
deposited in GenBank (accession number GU212863). One
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Rh. sanguineus pool contained a DNA fragment that was 99%
similar to fragments from Rickettsia africae and Rickettsia
conorii caspia. Its sequence was deposited in GenBank (acces-
sion number GU212860).
Rickettsial ompA DNA was found in 38 of the 51 gltA-posi-
tive Rh. turanicus pools (Table 1): 32 Rh. turanicus pools were
found to be positive for R. massiliae (sequence deposited
under GenBank accession number GU212859); ompA DNA
from ﬁve Rh. turanicus pools was found to be 99% similar to
that of R. conorii caspia (deposited under GenBank accession
number GU212861). The gltA fragment of three of these
ﬁve pools was 100% similar to that of R. conorii israelensis
(ISTT CDC1, accession number U59727), as well as to
those of other rickettsiae, with one base change (adenine
instead of guanine at position 58) as compared with the
other two pools, which were 99% similar to this R. conorii
israelensis. One Rh. turanicus pool contained a DNA fragment
that was 99% similar to those of R. africae and R. conorii
caspia (deposited under GenBank accession number
GU212860).
Rickettsial ompA DNA was found in two Hyalomma sp.
ticks. DNA of a Rickettsia sibirica mongolitimonae strain (new
GenBank accession number GU212862) was found in one
Hyalomma sp. tick (from Or Haner in the south). An ompA
fragment was identiﬁed in an additional Hyalomma sp. tick
(from Bror Hail in the south). The sequence of the latter
fragment was 99% similar to that of R. conorii caspia. It was
deposited in GenBank (accession number GU212861).
R. massiliae and R. conorii israelensis DNA were detected in
ticks from all three geographical regions.
Discussion
This study reports the ﬁrst molecular detection of R. massi-
liae and R. sibirica mongolitimonae in ticks from Israel. This is
the ﬁrst report describing the molecular detection of these
human pathogens in the Middle East.
R. massiliae was described and isolated in 1992 from
Rh. sanguineus ticks in Marseilles [8]. Actually, it was isolated
initially in 1985 from a patient in Palermo, Italy, who suffered
from fever, an eschar and a maculopapular rash [9]. But this
isolate was stored for 20 years and identiﬁed only in 2005 as
R. massiliae. A second human case was recently reported in
France [10]. Clinical signs included fever, night sweats, head-
ache, skin necrotic lesions and a maculopapular rash. To
date, R. massiliae has been detected and reported in Rhipi-
cephalus sp. ticks in Europe, Africa and America (Argentina,
and recently in Arizona, USA) [1,11]. In fact, R. massiliae is
the sole pathogenic tick-borne rickettsia reported to occur
on all three continents [1]. This study indicates, for the ﬁrst
time, that R. massiliae is prevalent in ticks from Israel, both in
Rh. sanguineous and in Rh. turanicus. To the best of our
knowledge, this is the ﬁrst report of R. massiliae detection in
Asia.
ISF is widely distributed throughout the Mediterranean
basin and the Middle East [12]. R. conorii israelensis has been
identiﬁed in Israel, Italy and Portugal [13–15]. The predomi-
nant symptoms of ISF include fever, headache, rash, myositis,
myalgia, and arthralgia [12,16]. Appearance of an eschar at
the tick bite site is also a common ﬁnding in ISF [12]. The
manifestation of the disease, which may be fatal, varies from
mild to severe [15]. Previous reports have documented
that R. conorii israelensis is prevalent in Israel mainly in two
foci, one in the northern Hadera-Caesarea region, and the
other in the southern Reim-Tzeelim region [3,17]. This
study indicates that this rickettsial pathogen is prevalent in
Rh. sanguineus ticks from many geographical regions in Israel,
from Caesarea in the north to Kibbutz Tzeelim in the south.
In this study, an ompA gene fragment (GenBank accession
number GU212861), which was 99% similar to that of R. co-
norii caspia, was identiﬁed in ﬁve Rh. turanicus pools and in
one Hyalomma sp. tick. This rickettsia, previously designated
as Rickettsia sp. Chad, is endemic in the Caspian Sea area. It
was isolated for the ﬁrst time from a soldier in Chad. The
patient had fever, chills, headache, a generalized purpuric
cutaneous rash, an inoculation eschar and dyspnoea resulting
from interstitial pneumonia [18]. The ompA fragment identi-
ﬁed in the current study was 98% similar to that of R. conorii
israelensis. The gltA fragment from three of the ﬁve Rh. turani-
cus pools in this study was 100% similar to the counterpart
TABLE 1. Similarities of outer membrane protein A (ompA)
gene sequences, detected in ticks from Israel, with
GenBank-deposited sequences
Tick
Rickettsial ompA (% identity; number
of base pairs)
Number of pools/ticks
Rhipicephalus sanguineus Rickettsia massiliae (100% EU448165; 180 bp)
12 pools
Rickettsia conorii israelensis
(100% EF177482.1; 180 bp)
three pools
Rickettsia africae, Rickettsia conorii caspia
(99% CP001612.1; 178 bp)
one pool
Rhipicephalus turanicus R. massiliae (100% EU448165; 180 bp)
32 pools
R. conorii caspia (99% U43791.1; 182 bp)
ﬁve pools
R. africae, R. conorii caspia
(99% CP001612.1; 178 bp)
one pool
Hyalomma sp. Rickettsia sibirica mongolitimonae
(100% DQ423367.1; 182 bp)
one tick
R. conorii caspia (99% U43791.1; 182 bp)
one tick
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of R. conorii israelensis, whereas the fragments from the
remaining two pools were 99% similar, with only a single
nucleotide difference. As these DNA fragments were identi-
ﬁed in tick pools and the sequences could be obtained
from different individual ticks, infection of individual ticks
with different rickettsiae is possible. Co-infection with both
R. conorii caspia and R. conorii israelensis is also a possibility.
Another option is that the gltA and ompA fragments ampliﬁed
were retrieved from the same strain, and the rickettsia
detected in the ﬁve Rh. turanicus pools was a strain of R. co-
norii israelensis and not R. conorii caspia. In the case of any of
these options, to the best of the authors’ knowledge, this is
the ﬁrst molecular evidence of R. conorii israelensis infection
in Rh. turanicus ticks. Further molecular analysis is needed to
deﬁnitely ascertain the identity of this rickettsial strain.
R. sibirica mongolitimonae DNA was found in one Hya-
lomma sp. tick. This rickettsia was ﬁrst detected in Hyalomma
asiaticum ticks from Mongolia [19]. Since then, it has been
detected in Hyalomma truncatum from Niger [20], and has
been associated with human infections in Greece, France,
Spain, Portugal and South Africa [21–25]. The disease caused
by this rickettsia is manifested by headache, fever, eschar for-
mation, lymphangitis and lymphadenopathy [23]. To the best
of our knowledge, this is the ﬁrst report on the presence of
R. sibirica mongolitimonae in Israel and the Middle East.
The presence of rickettsiae in free, questing adult ticks
collected from the vegetation indicated that the ticks
included in this study were subject to the rickettsial infesta-
tion at an earlier stage of their development. In the case of
Rh. sanguineus, it has been shown that R. conorii is transmit-
ted transovarially and transstadially [26,27]. To the best of
our knowledge, the mode of transmission of the other rick-
ettsiae detected in the corresponding ticks in this study,
whether transovarial and/or transstadial, is not known. The
current ﬁndings suggest transstadial transmission of the latter
rickettsiae from the nymphal to the adult stage.
The molecular ﬁndings of this study suggest an
increased variety and distribution of rickettsial organisms
in novel geographical niches. The possibility that these
pathogens existed in the region for many years but were
erroneously diagnosed as R. conorii israelensis, a prevalent
species in this region, cannot be ruled out; however, this
is less likely. Reasons for the possible increased variety
and widespread distribution of rickettsiae in this region
may be associated with climate and other global changes
[6]. Global warming has been suggested to increase the
distribution regions of arthropod vectors and the effective-
ness of pathogen transmission within them, and it has
been associated with the emergence of severe rickettsioses
[10,28]. Another possible mode of distribution is the
introduction of infected ticks by migrating birds. Rickettsia
aeschilimannii, Rickettsia helvetica and R. massiliae were iden-
tiﬁed in Hyalomma marginatum, Ixodes ventalloi and Rh. tura-
nicus, respectively, which were collected from migrating
wild birds [29]. As Israel is located on the main route of
migrating birds from Europe and Asia to Africa, this mode
of transmission is plausible.
In conclusion, this study reports the ﬁrst detection of
R. massiliae and R. sibirica mongolitimonae in ticks from Israel.
Physicians should be aware of the emergence of these human
pathogens in the eastern Mediterranean region.
Transparency Declaration
The authors declare no dual or conﬂicting interests.
References
1. Berrelha J, Briolant S, Muller F et al. Rickettsia felis and Rickettsia massi-
liae in Ivory Coast, Africa. Clin Microbiol Infect 2009; doi: 10.1111/
j.1469-0691.2008.02273.x [Epub ahead of print].
2. Parola P, Davoust B, Raoult D. Tick- and ﬂea-borne rickettsial emerg-
ing zoonoses. Vet Res 2005; 36: 469–492.
3. Guberman D, Mumcuoglu KY, Keysary A, Ioffe-Uspensky I, Miller J,
Galun R. Prevalence of spotted fever group rickettsiae in ticks from
southern Israel. J Med Entomol 1996; 33: 979–982.
4. Zhu Y, Fournier PE, Eremeeva M, Raoult D. Proposal to create sub-
species of Rickettsia conorii based on multilocus sequence typing and
an emended description of Rickettsia conorii. BMC Microbiol 2005; 5:
1–11.
5. Bauer O, Baneth G, Eshkol T, Shaw SE, Harrus S. Polygenic detection
of Rickettsia felis in cat ﬂeas (Ctenocephalides felis) from Israel. Am J
Trop Med Hyg 2006; 74: 444–448.
6. Harrus S, Baneth G. Drivers for the emergence and re-emergence of
vector-borne protozoal and bacterial diseases. Int J Parasitol 2005; 35:
1309–1318.
7. Kidd L, Maggi R, Diniz PP, Hegarty B, Tucker M, Breitschwerdt E.
Evaluation of conventional and real-time PCR assays for detection
and differentiation of spotted fever group rickettsia in dog blood. Vet
Microbiol 2008; 29: 294–303.
8. Beati L, Raoult D. Rickettsia massiliae sp. nov., a new spotted fever
group rickettsia. Int J Syst Bacteriol 1993; 43: 839–840.
9. Vitale G, Mansueto S, Rolain JM, Raoult D. Rickettsia massiliae: ﬁrst
isolation from the blood of a patient. Emerg Infect Dis 2006; 12: 174–
175.
10. Parola P, Socolovschi C, Jeanjean L et al. Warmer weather linked to
tick attack and emergence of severe rickettsioses. PloS Negl Trop Dis
2008; 2: e338. [Epub ahead of print].
11. Parola P, Paddock C, Raoult D. Tick-borne rickettsioses around the
world: emerging diseases challenging old concepts. Clin Microbiol Rev
2005; 18: 719–756.
12. Raoult D, Wieller PJ, Chagnon A, Chaudet H, Gallais H, Casanova P.
Mediterranean spotted fever: clinical, laboratory and epidemiological
features of 199 cases. Am J Trop Med Hyg 1986; 35: 845–850.
13. Giammanco GM, Vitale G, Mansueto S, Capra G, Caleca MP, Ammat-
una P. Presence of Rickettsia conorii subsp. israelensis, the causative
CMI Harrus et al. Molecular detection of SFG rickettsiae from ticks in Israel 179
ª2010 The Authors
Journal Compilation ª2010 European Society of Clinical Microbiology and Infectious Diseases, CMI, 17, 176–180
agent of Israeli spotted fever, in Sicily, Italy, ascertained in a retro-
spective study. J Clin Microbiol 2005; 43: 6027–6031.
14. de Sousa R, Santos-Silva M, Santos AS et al. Rickettsia conorii Israeli
tick typhus strain isolated from Rhipicephalus sanguineus ticks in Por-
tugal. Vector Borne Zoonotic Dis 2007; 7: 444–447.
15. Weinberger M, Keysary A, Sandbank J et al. Fatal Rickettsia conorii
subsp. israelensis infection, Israel. Emerg Infect Dis 2008; 14: 821–824.
16. Wolach B, Franco S, Bogger-Goren S et al. Clinical and laboratory
ﬁndings of spotted fever in Israeli children. Pediatr Infect Dis J 1989; 8:
152–155.
17. Harrus S, Lior Y, Ephros M et al. Rickettsia conorii in humans and dogs:
a seroepidemiologic survey of two rural villages in Israel. Am J Trop
Med Hyg 2007; 77: 133–135.
18. Fournier P, Xeridat EB, Raoult D. Isolation of a rickettsia related to
Astrakhan fever rickettsia from a patient in Chad. Ann NY Acad Sci
2003; 990: 152–157.
19. Yu X, Fan M, Xu G, Liu Q, Raoult D. Genotypic and antigenic identi-
ﬁcation of two new strains of spotted fever group rickettsiae isolated
from China. J Clin Microbiol 1993; 31: 83–88.
20. Parola P, Inokuma H, Camicas JL, Brouqui P, Raoult D. Detection
and identiﬁcation of spotted fever group rickettsiae and Ehrlichiae in
African ticks. Emerg Infect Dis 2001; 7: 1014–1017.
21. Psaroulaki A, Germanakis A, Gikas A, Scoulica E, Tselentis Y. Simulta-
neous detection of Rickettsia mongolotimonae in a patient and in a tick
in Greece. J Clin Microbiol 2005; 43: 3558–3559.
22. Fournier PE, Tissot-Dupont H, Gallais H, Raoult DR. Rickettsia mon-
golotimonae: a rare pathogen in France. Emerg Infect Dis 2000; 6: 290–
292.
23. Pretorius AM, Birtles RJ. Rickettsia mongolotimonae infection in South
Africa. Emerg Infect Dis 2004; 10: 125–126.
24. de Sousa R, Duque L, Poc¸as J et al. Portuguese patient infected with
Rickettsia sibirica. Emerg Infect Dis 2008; 14: 529–531.
25. Aguirrebengoa K, Portillo A, Santiba´n˜ez S, Marı´n JJ, Montejo M, Oteo
JA. Human Rickettsia sibirica mongolitimonae infection, Spain. Emerg
Infect Dis 2008; 14: 528–529.
26. Levin ML, Killmaster L, Zemtsova G et al. Incongruent effects of two
isolates of Rickettsia conorii on the survival of Rhipicephalus sanguineus
ticks. Exp Appl Acarol 2009; 49: 347–359.
27. Neitz WO, Alexander RA, Mason JH. The transmission of tick-bite
fever by the dog tick Rhipicephalus sanguineus. Onderstepoort J Vet Sci
Anim Ind 1941; 16: 9–17.
28. Gubler DJ, Reiter P, Ebi KL, Yap W, Nasci R, Patz JA. Climate vari-
ability and change in the United States: potential impacts on vector-
and rodent-borne diseases. Environ Health Perspect 2001; 109 (suppl
2): 223–233.
29. Stenos J, Graves SR, Unsworth NB. A highly sensitive and speciﬁc
real-time PCR assay for the detection of spotted fever and typhus
group rickettsiae. Am J Trop Med Hyg 2005; 73: 1083–1085.
180 Clinical Microbiology and Infection, Volume 17 Number 2, February 2011 CMI
ª2010 The Authors
Journal Compilation ª2010 European Society of Clinical Microbiology and Infectious Diseases, CMI, 17, 176–180
